Patents by Inventor Sarah Amy Penny

Sarah Amy Penny has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10682399
    Abstract: A set of target peptides are presented by HLA A*0201, B*0301, B*0702 and B*2705 on the surface of disease cells. They are envisioned to, among other things, stimulate an immune response to the proliferative disease, e.g., colorectal cancer, to function as immunotherapeutics in adoptive T cell therapy or as a vaccine, facilitate antibody recognition of tumor boundaries in surgical pathology samples, act as biomarkers for early detection and/or diagnosis of the disease, and/or act as targets in the generation antibody-like molecules which recognize the target-peptide/MHC complex.
    Type: Grant
    Filed: September 5, 2013
    Date of Patent: June 16, 2020
    Assignees: The University of Birmingham, University of Virginia Patent Foundation
    Inventors: Donald F. Hunt, Jeffrey Shabanowitz, Jennifer G. Abelin, Mark Cobbold, Sarah Amy Penny
  • Publication number: 20150328297
    Abstract: A set of target peptides are presented by HLA A*0201, B*0301, B*0702 and B*2705 on the surface of disease cells. They are envisioned to, among other things, stimulate an immune response to the proliferative disease, e.g., colorectal cancer, to function as immunotherapeutics in adoptive T cell therapy or as a vaccine, facilitate antibody recognition of tumor boundaries in surgical pathology samples, act as biomarkers for early detection and/or diagnosis of the disease, and/or act as targets in the generation antibody-like molecules which recognize the target-peptide/MHC complex.
    Type: Application
    Filed: September 5, 2013
    Publication date: November 19, 2015
    Inventors: Donald F. Hunt, Jeffrey Shabanowitz, Jennifer G. Abelin, Mark Cobbold, Sarah Amy Penny